ImpactofBaselineAnemiainPatientsWithAcuteCoronarySyndromesUndergoingPercutaneousCoronaryIntervention:APrespecifiedAnalysisFromtheVALIDATE‐SWEDEHEARTTrialJAHAresearch-articleAug20,:8(16),e./JAHA..本文由“天纳”临床学术信息人工智能系统自动翻译点击文末“阅读原文”下载本文PDFBackgroundTheimpactofbaselineanemiainacontemporaryacutecoronarysyndrome(ACS)populationundergoingpercutaneouscoronaryinterventionintheeraofpredominantradialarteryaccess,potentP2Y12inhibition,andrareuseofglycoproteinIIb/IIIainhibitorshasnotbeenadequatelystudied.在主要的桡动脉通路、有效的p2y12抑制和极少使用糖蛋白IIb/IIia抑制剂的时代，接受经皮冠状动脉介入治疗的当代急性冠状动脉综合征（ACS）患者基线贫血的影响尚未得到充分研究。MethodsandResultsACSpatientswhounderwentpercutaneouscoronaryinterventionbetweenandintheVALIDATE‐SWEDEHEART(BivalirudinVersusHeparininST‐SegmentandNon–ST‐SegmentElevationMyocardialInfarctioninPatientsonModernAntiplateletTherapyintheSwedishWebSystemforEnhancementandDevelopmentofEvidence‐BasedCareinHeartDiseaseEvaluatedAccordingtoRe
白癜风治疗最好的药白癜风治疗最好的药
转载请注明：http://www.gpanp.com/yhsw/4834.html
